News
African-Caribbean ethnicity key risk factor for sight-threatening diabetic eye disease
People of African-Caribbean ethnicity with Type 2 diabetes are a third more likely to develop a condition called sight-threatening diabetic retinopathy (STDR) than other ethnic groups, according to researchers from King’s College London. The study, published in the journal Diabetes...
Survey: Dacryocystorhinostomy International Practice
Dacryocystorhinostomy (DCR) is widely recognised as the gold-standard surgical intervention for managing nasolacrimal duct obstruction, particularly when medical therapy fails to restore adequate lacrimal drainage. Both external and endonasal (endoscopic) DCR approaches have evolved considerably over recent decades, with technological...
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...
Nominations now open for the College’s President’s Research Medal
The President’s Research Medal recognises and celebrates outstanding contributions to research and recognises a lifetime's career in optometric, eye health or vision science research. The President’s Research Medal is the College’s most prestigious research award. The winners of this award...
OPO celebration event marks 100-years of groundbreaking research in vision science and optometry
The College of Optometrists hosted academics from across the UK and internationally at a special symposium to mark 100-years of its research journal Ophthalmic and Physiological Optics (OPO) at Glasgow Caledonian University. OPO Centenary: Celebrating Research Excellence saw academics and...
AI predicts eye damage from autoimmune drug, years before symptoms appear
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...
Hope for young children with impaired eye sight caused by Albinism
The University of Southampton has been awarded over half a million pounds for groundbreaking research aimed at improving the vision of children born with Albinism. Albinism affects the production of melanin – pigment which colours eyes, skin and hair. It...
The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....
Seeing with fresh eyes: Snails as a system for studying sight restoration
Stowers scientists have established the apple snail as a new research organism for investigating eye regeneration, which may hold the key for restoring vision due to damage and disease. Snails are slimy, simple creatures yet one species, the apple snail,...
Glaucoma UK announces the recipients of its 2025 project grants
Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. The recipients are: Associate Professor Kuang Hu, at UCL Institute of Ophthalmology. His project is...
Early detection key to improving treatment of uveitis, a leading cause globally of vision loss
New treatment guidance has been developed to help doctors tackle uveitis — one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep this...
Major grant secured to transform immune cell imaging research
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...
